Based on this dual role of tumor suppressor and antiviral effector, oncogene-mediated targeting of PKR in general, and its inhibition by the RAS/RAF/MEK/ERK pathway in particular, can be exploited by OVs. This evidence concerns the gene EIF2AK2 and neoplasm.